(Q43510164)

English

Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response

scientific article published on 11 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Giuliana Alimena

9

object named as

Giuliana Alimena

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Massimo Breccia

1

object named as

Massimo Breccia

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Giuseppina Loglisci

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Laura Cannella

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Paola Finsinger

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Marco Mancini

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Alessandra Serrao

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Michelina Santopietro

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Adriano Salaroli

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

11 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

985-986

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.643408

21 January 2018

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.643408

21 January 2018

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.643408

21 January 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.643408

21 January 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.643408

21 January 2018

Identifiers

10.3109/10428194.2011.643408

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

release_lnsjuvqvwjd5fnoc4syrtnfa2q

1 reference

https://api.fatcat.wiki/v0/release/lnsjuvqvwjd5fnoc4syrtnfa2q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43510164&oldid=1990229222"